Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-12-02

Clinical Trial Update: Autologous Plasmin and Fibrinolytic System in Diabetic Retinopathy [NA]

View source ↗

Summary

This entry describes a clinical trial investigating autologous plasmin and a fibrinolytic system for diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous plasmin and fibrinolytic system (plasmin)

Snippet

Sponsor: Hallym University Medical Center | Conditions: Macular Edema | NA | Status: UNKNOWN